Inventor · disambiguated record
Yingcai Wang
Also filed as: WANG YINGCAI · WANG YINGCAI (IAN)
19 granted patents·13 pending applications·212 citations·filing 2003–2023
94Inventor score
Top patents by PatentIndex Score
32 records- 0195US7541383B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2007·Granted Jun 2, 2009·86 cites·24 claims
- 0294US7582803B2Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2006·Granted Sep 1, 2009·17 cites·19 claims
- 0389US7816367B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Oct 19, 2010·15 cites·25 claims
- 0488US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0588US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0688US7321001B2Asthma and allergic inflammation modulatorsAMGEN INC·Filed 2003·Granted Jan 22, 2008·39 cites·25 claims
- 0787US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 0886US8030354B2Substituted biphenyl GPR40 modulatorsAMGEN INC·Filed 2008·Granted Oct 4, 2011·11 cites·96 claims
- 0985US7649110B2Compounds, pharmaceutical compositions and methods for use in treating metabolic disordersAMGEN INC·Filed 2005·Granted Jan 19, 2010·8 cites·37 claims
- 1083US8450522B2Conformationally constrained carboxylic acid derivatives useful for treating metabolic disordersBROWN SEAN P·Filed 2009·Granted May 28, 2013·9 cites·17 claims
- 1183US7687526B2Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2007·Granted Mar 30, 2010·5 cites·18 claims
- 1281US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1380US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 1478US7465804B2Compounds, pharmaceutical compositions and methods for their use in treating metabolic disordersAMGEN INC·Filed 2006·Granted Dec 16, 2008·3 cites·48 claims
- 1574US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1673US8748462B2Spirocyclic GPR40 modulatorsBROWN SEAN P·Filed 2009·Granted Jun 10, 2014·2 cites·25 claims
- 1773US8003648B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2009·Granted Aug 23, 2011·1 cites·10 claims
- 1869US8183293B2Phenyl acetic acid derivativesGRILLO MARK·Filed 2008·Granted May 22, 2012·2 cites·20 claims
- 1967US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2065US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2164US2009275598A1Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disordersAMGEN INC·Filed 2009·Application pending·0 cites
- 2264US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2356US7714008B2Heterocyclic GPR40 modulatorsAMGEN INC·Filed 2007·Granted May 11, 2010·0 cites·11 claims
- 2456US2020289659A1Conjugates for treating diseasesENDOCYTE INC·Filed 2020·Application pending·0 cites
- 2554US2025108119A1NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOFIMMUNEXT INC·Filed 2022·Application pending·0 cites
- 2651US2023310634A1Anti-human vista antibodies and use thereofIMMUNEXT INC·Filed 2021·Application pending·0 cites
- 2750US7960567B2Compounds and methods useful for treating asthma and allergic inflammationAMGEN INC·Filed 2008·Granted Jun 14, 2011·0 cites·19 claims
- 2848US12502386B2Nitrogen-containing heterocyclic compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·19 claims
- 2947US2025304608A1Phosphorus compound and use thereofSHANGHAI SHIJIANG BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 3046US2007244155A1Bicyclic carboxylic acid derivatives useful for treating metabolic disordersAMGEN INC·Filed 2007·Application pending·0 cites
- 3143US2010137323A1Benzo-fused compounds for use in treating metabolic disordersAMGEN INC·Filed 2010·Application pending·0 cites
- 3238US10624972B2Conjugates for treating diseasesENDOCYTE INC·Filed 2015·Granted Apr 21, 2020·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Yingcai Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →